NTRBW Company Profile and Key Details

Nutriband Inc. (NASDAQ:NTRBW) closed at $0.97 USD, gaining $0.58 (149.74%) from the previous close of $0.39. The stock is currently mid-range between its 52-week high and low $0.17 and $2.99. With a market capitalization of about $133.08 million, Nutriband Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.97). Key stats such as the average daily volume over the past year has been around 3.05 thousand shares, trading with heavier-than-usual volume. Headquartered in Orlando, FL, Nutriband Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Gareth Sheridan, the company employs approximately 3 people and listed since October 01, 2021. Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products.

Nutriband Inc. earnings surprise history is frequent misses against expectations. The quarter that ended May 01, 2026, missed forecasts by -98.94%. The prior quarter beat by -98.94%. Over the last six quarters, Apple has recorded several small beats. These include -0.38% in April 28, 2025.

NTRBW has shown mixed momentum, losing 0.0% over the past week and -23.57% over the past quarter, though year-to-date performance is down -90.44%. Average 10-day trading volume of 6.29 thousand shares is slightly above the 3-month average of 4.38 thousand, indicating heightened recent market interest.

Nutriband Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.74. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Nutriband Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -23.52%, with price expected at $0.46 by November 24, 2023, within a range of $0.33 to $0.61

Nutriband Inc. (NASDAQ:NTRBW) shares are down -90.44% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Nutriband Inc. trading at a premium to the broader market with a P/E of -11.71.

Nutriband Inc. trades at a P/E ratio of -11.71, slightly below the S&P 500 average, with a price-to-sales ratio of 50.35 and a price-to-book ratio of 15.28 reflecting a rich premium to book value. The P/FCF stands at -22.42, also below market averages. Compared to sector medians, Nutriband Inc. P/S is trading rich, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.